Frances Belcher
About Frances Belcher
Frances Belcher is a Group Leader in Stem Cell Process Development at Adaptimmune, where she has worked since 2020. She has a strong academic background with a Ph.D. from the University of London and has held various research positions in both industry and academia.
Current Role at Adaptimmune
Frances Belcher currently serves as the Group Leader for Stem Cell Process Development at Adaptimmune. She has held this position since 2020. In her role, she is responsible for leading initiatives related to stem cell processes, contributing to the company's focus on developing innovative therapies.
Previous Experience at Adaptimmune Limited
Frances Belcher worked as a Senior Scientist at Adaptimmune Limited from 2017 to 2020. During her three years in this role, she contributed to various research projects and initiatives aimed at advancing the company's scientific objectives in the field of immunotherapy.
Educational Background
Frances Belcher studied at the University of London, where she earned her Doctor of Philosophy (Ph.D.) degree from 1987 to 1992. Her research focused on the Role of Inflammatory Cytokines in Renal Failure. She also holds a Bachelor’s Degree in Biology/Biological Sciences from the University of Nottingham, which she completed from 1982 to 1985.
Postdoctoral Research Experience
Frances Belcher has held postdoctoral researcher positions at both St George's, University of London, from 1992 to 1993, and the University of Sheffield from 1993 to 1995. These roles contributed to her expertise in biological sciences and research methodologies.
Previous Role at ProImmune, Ltd.
Prior to her current role, Frances Belcher worked as a Cellular Services Assistant at ProImmune, Ltd. from 2016 to 2017. In this position, she was involved in cellular services, supporting the company's research and development efforts.